Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peripheral arterial smooth muscle refers to the smooth muscle cells predominantly located in the medial layer of peripheral arteries. These cells are essential for vessel contraction and relaxation, regulating blood flow and blood pressure. VSMCs show plasticity, switching phenotypes in response to injury or disease, and play central roles in vascular remodeling, arterial stiffness, calcification, and the pathogenesis of cardiovascular diseases such as hypertension, atherosclerosis, and peripheral artery disease. Drugs exert therapeutic effects on the vasculature by acting on molecular targets within these cells. In summary, "peripheral arterial smooth muscle" is a tissue/cell population, not a canonical molecular or receptor target. For pharmacological or structured data purposes, the specific molecule or receptor of interest (such as "L-type calcium channel, alpha-1C subunit," or "angiotensin II receptor type 1") should be used instead.
None specific (see above — drugs act via targets in VSMCs: e.g., Ca2+ channel blocking leads to vasodilation; angiotensin receptor antagonism reduces vasoconstriction)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vascular smooth muscle cell (peripheral artery) (VSMC).